Showing results (831-840 of 5,443) with videos related to
Sort By:
Pageof 545
Bulletin Du Cancer|January 1, 1975
[Chemical cancerization of hamster embryo cells in mass culture]P Markovits, P Daudel, D Papadopoulo, et al.Bulletin Du Cancer|February 1, 1993
[Intraperitoneal administration of interferon gamma. An efficient adjuvant to the chemotherapy of ovarian cancers. Apropos of an European study of 108 patients]E Pujade-Lauraine, J P Guastella, N Colombo, et al.Bulletin Du Cancer|April 1, 1993
[Paraneoplastic syndromes (2)]A Lortholary, M Cossee, E Gamelin, et al.Bulletin Du Cancer|April 1, 1993
[Should comparison be made between survival of responding vs. non-responding patients?]C HillBulletin Du Cancer|April 1, 1993
[In vitro characterization of S9788, a new modulator of multidrug resistance]V Pérez, A Pierré, S Léonce, et al.Bulletin Du Cancer|May 1, 1993
Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic miceJ Wdzieczak-Bakala, C Grillon, S Robinson, et al.Bulletin Du Cancer|May 1, 1993
[Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers]M de Forni, V Gualano, P Canal, et al.Bulletin Du Cancer|May 1, 1993
[Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors]P Berthaud, I Eugène-Jolchine, M Spielmann, et al.Bulletin Du Cancer|December 1, 1994
[Drug resistance of human tumors: from the laboratory to the clinic]M MousseauBulletin Du Cancer|December 1, 1994
[Methods for diagnosing MDR: immunohistochemistry versus molecular biology]M MousseauPageof 545